Adherence to dietary supplementation with menaquinone-7, a vitamin K2 analogue
Aim: The VitaK-CAC (vitamin K-coronary artery calcification) trial is a double-blind, randomized, placebo-controlled trial in patients with pre-existent CAC who were treated for two years with either placebo or the vitamin K2-analogue menaquinone-7 (MK-7). The purpose of the present analysis of the...
Saved in:
| Main Authors: | Liv M Vossen, Leon J Schurgers, Claudia de Haan, Abraham A Kroon, Peter W de Leeuw |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Exploration Publishing Inc.
2025-05-01
|
| Series: | Exploration of Medicine |
| Subjects: | |
| Online Access: | https://www.explorationpub.com/uploads/Article/A1001321/1001321.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low Vitamin K Status and Risk of Chronic Obstructive Pulmonary Disease
by: Daniel Alexander Ackermann, et al.
Published: (2025-03-01) -
A bioprocess optimization study to enhance the production of Menaquinone-7 using Bacillus subtilis MM26
by: Maneesha M, et al.
Published: (2025-05-01) -
Low vitamin K status is a potential risk factor for COVID-19 infected patients: a systematic review and meta-analysis
by: Wei Liu, et al.
Published: (2025-04-01) -
Combination of SPH and SP80 prolongs the lifespan of Bacillus subtilis natto to enhance industrial menaquinone-7 biosynthesis
by: Liu-xiu Hu, et al.
Published: (2025-06-01) -
Vitamin K1 and K2: Biochemistry, Clinical Significance, and Therapeutic Potential in Human Healt
by: Michał Wycik, et al.
Published: (2025-07-01)